Xavier Jacq

Xavier Jacq serves as the Chief Scientific Officer at MitoRx Therapeutics since May 2025 and has held the position of Non-Executive Director at Evariste since May 2024. Notable previous roles include Scientific Advisory Board Member at Ubiquigent Ltd and Chief Scientific Officer at MoA Technology. Xavier has made significant contributions to academia as an Honorary Senior Lecturer at Queen's University Belfast and has extensive experience in leadership positions, including Senior Vice President at Dunad Therapeutics and Vice President of Biology at Almac Group. Xavier's academic background includes a PostDoctorate in Oncology from Columbia University, a PhD in Biochemistry from Université Louis Pasteur, and a Bachelor's degree in Biochemistry, Biophysics, and Molecular Biology from the University of Montpellier.